Mukka Proteins Limited — Credit Ratings, 15-01-2025: Credit Rating

Consolidated financials were not provided, so the focus is on standalone financial results. The company has reported a significant revenue increase of 260% with total revenue reaching ₹360 crore, driven by rising demand and market expansion efforts, alongside improvements in operational efficiency.

Net profit surged to ₹48 crore, marking a year-over-year increase, with an EPS of ₹4.80. Factors influencing profitability include enhanced margins from cost control initiatives and operational efficiencies, despite some fluctuations in raw material costs.

Operational costs increased to ₹120 crore, reflecting a 30% rise, primarily due to higher freight charges and labor costs linked to expanded production capacity. This escalation indicates the company's ongoing investment in growth, though it highlights the need for continued focus on cost management strategies.

The balance sheet appears solid, with total assets noted at ₹500 crore, and a healthy cash flow statement supports ongoing operations and strategic investments. The company is well-positioned to navigate the current market dynamics while focusing on innovation and efficiency.

The recent credit rating upgrade to CARE BBB+ with a stable outlook suggests a positive view on financial health and revenue stability, which can lower borrowing costs and enhance investor sentiment. Considering the strong financial performance and strategic opportunities, the insight leans towards a buy perspective, reflecting confidence in future growth potential.